Tryptamine Therapeutics Enrolls Second Patient, Prepares First Dosing in Groundbreaking BED Trial

middle.news 9:04am on Tuesday 18th of November, 2025 AEDT • Healthcare Read Story

Tryptamine Therapeutics Enrolls Second Patient, Prepares First Dosing in Groundbreaking BED Trial

9:04am on Tuesday 18th of November, 2025 AEDT Key Points Second patient enrolled in world-first TRP-8803 trial for Binge Eating Disorder First patient dosing scheduled for 1 December 2025 Trial involves 12 patients across two dose cohorts with supportive therapy Butterfly Foundation supports recruitment and awareness efforts Read Story

middle. Tap to Read Tap the card to read the full analysis about TYP OPEN ARTICLE